Optimizing bulk segregant analysis of drug resistance using Plasmodium falciparum genetic crosses conducted in humanized mice

利用在人源化小鼠中进行的恶性疟原虫遗传杂交,优化药物耐药性的群体分离分析

阅读:7
作者:Katelyn Vendrely Brenneman ,Xue Li ,Sudhir Kumar ,Elizabeth Delgado ,Lisa A Checkley ,Douglas A Shoue ,Ann Reyes ,Biley A Abatiyow ,Meseret T Haile ,Rupam Tripura ,Tom Peto ,Dysoley Lek ,Katrina A Button-Simons ,Stefan H I Kappe ,Mehul Dhorda ,François Nosten ,Standwell C Nkhoma ,Ian H Cheeseman ,Ashley M Vaughan ,Michael T Ferdig ,Tim J C Anderson

Abstract

Classical malaria parasite genetic crosses involve isolation, genotyping, and phenotyping of progeny parasites, which is time consuming and laborious. We tested a rapid alternative approach-bulk segregant analysis (BSA)-that utilizes sequencing of bulk progeny populations with and without drug selection for rapid identification of drug resistance loci. We used dihydroartemisinin (DHA) selection in two genetic crosses and investigated how synchronization, cryopreservation, and the drug selection regimen impacted BSA success. We detected a robust quantitative trait locus (QTL) at kelch13 in both crosses but did not detect QTLs at four other candidate loci. QTLs were detected using synchronized, but not unsynchronized progeny pools, consistent with the stage-specific action of DHA. We also successfully applied BSA to cryopreserved progeny pools, expanding the utility of this approach. We conclude that BSA provides a powerful approach for investigating the genetic architecture of drug resistance in Plasmodium falciparum. Keywords: Biological sciences; Genomics; Parasitology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。